Evolus Inc. Investor Presentation January 2021

Evolus Inc. investor presentation from January 2021 discussing the company's Jeuveau® product portfolio, commercial launch strategy, and planned Phase II clinical trials for an extra-strength formulation. The presentation addresses market positioning, competitive dynamics, regulatory compliance, and financial performance of the aesthetic medicine company.